PGNY (Progyny) Total Equity: $439 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

PGNY Progyny Inc PGNY
94 GF Score
Price $31.13
GF Value $28.60
Valuation Fairly Valued
! 6 Warning Signs
View Full Analysis

What is Progyny Total Equity?

Progyny PGNY -1.11% 94 Total Equity is $439 Mil as of Mar. 2026. GuruFocus rates PGNY with a GF Score™ of 94/100 and a GF Value™ of $28.60 (Fairly Valued). The stock has 6 warning signs investors should review.

Progyny's total equity for the quarter that ended in Mar. 2026 was $439 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Progyny Total Equity Historical Data

* Premium members only.

The historical data trend for Progyny's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Progyny Total Equity Chart

Progyny Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Equity
Get a 7-Day Free Trial Premium Member Only 251.82 376.97 553.43 422.06 516.04

Progyny Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 467.16 515.02 560.00 516.04 439.34
PGNY
94GF Score
Progyny Inc PGNY
Total Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Progyny Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Progyny's Total Equity for the fiscal year that ended in Dec. 2025 is calculated as

Total Equity=Total Assets(Q: Dec. 2025 )-Total Liabilities(Q: Dec. 2025 )
=742.435-226.391
=516

Progyny's Total Equity for the quarter that ended in Mar. 2026 is calculated as

Total Equity=Total Assets(Q: Mar. 2026 )-Total Liabilities(Q: Mar. 2026 )
=698.337-258.993
=439

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Equity →
What does a Total Equity of $439 Mil mean?
Progyny (PGNY) has a Total Equity of $439 Mil as of Mar. 2026. The total amount of equity as record on a company's balance sheet. View historical data for Progyny and its competitors.
Is Progyny's Total Equity too high?
Progyny's current Total Equity is $439 Mil. Overall, Progyny has a GF Score™ of 94/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Progyny's Total Equity compare to CLOV and ALHC?
Progyny's Total Equity of $439 Mil can be compared against companies in the Healthcare Plans industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Equity for a Healthcare Plans company?
A good Total Equity depends on the Healthcare Plans industry context. However, Total Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Equity mean?
A high Total Equity can signal that a stock is expensive relative to its fundamentals. The total amount of equity as record on a company's balance sheet. View historical data for Progyny and its competitors. Progyny's current Total Equity is $439 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Progyny stock overvalued right now?
Based on GuruFocus' analysis, Progyny (PGNY) is currently considered Fairly Valued. The stock's GF Value™ is $28.60, compared to a current price of $31.13 — trading 8.8% above its estimated fair value. The current Total Equity is $439 Mil. Progyny's overall GF Score™ is 94/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Equity calculated?
Total Equity is calculated from a company's financial statements. For Progyny (PGNY), the current Total Equity is $439 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Progyny (PGNY) Overvalued in 2026?

Based on GuruFocus' analysis, Progyny stock appears to be overvalued. The current stock price of $31.13 is trading 8.8% above its estimated GF Value™ of $28.60. GuruFocus considers Progyny to be Fairly Valued.

Key valuation signals for PGNY:

  • Total Equity: $439 Mil
  • GF Value™: $28.60 vs. price of $31.13 (8.8% above fair value)
  • GF Score™: 94/100 with 6 warning signs

No single metric tells the full story. See the PGNY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Progyny Business Description

Address 1359 Broadway, New York, NY, USA, 10018
Progyny Inc is a benefits management company specializing in fertility, family building, and women's health benefits solutions. Its clients include employers across various industries. The fertility benefits solution consists of treatment services (Smart Cycles), access to the Progyny network of high-quality fertility specialists that perform the Smart Cycle treatments, and active management of the selective network of high-quality provider clinics.
94GF Score

Get the complete analysis for PGNY

Total Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$31.13
Price
$28.60
GF Value